Copyright Reports & Markets. All rights reserved.

Global Biologic Medications for Psoriasis Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Biologic Medications for Psoriasis Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 TNF-α Inhibitors
    • 1.3.3 Interleukin Inhibitors
    • 1.3.4 Tyrosine Kinase Inhibitors
    • 1.3.5 Phosphodiesterase Inhibitors
    • 1.3.6 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Biologic Medications for Psoriasis Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital and Clinic
    • 1.4.3 Retail Pharmacies
    • 1.4.4 Other
  • 1.5 Global Biologic Medications for Psoriasis Market Size & Forecast
    • 1.5.1 Global Biologic Medications for Psoriasis Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Biologic Medications for Psoriasis Sales Quantity (2021-2032)
    • 1.5.3 Global Biologic Medications for Psoriasis Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Bristol-Myers Squibb
    • 2.1.1 Bristol-Myers Squibb Details
    • 2.1.2 Bristol-Myers Squibb Major Business
    • 2.1.3 Bristol-Myers Squibb Biologic Medications for Psoriasis Product and Services
    • 2.1.4 Bristol-Myers Squibb Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Bristol-Myers Squibb Recent Developments/Updates
  • 2.2 Amgen
    • 2.2.1 Amgen Details
    • 2.2.2 Amgen Major Business
    • 2.2.3 Amgen Biologic Medications for Psoriasis Product and Services
    • 2.2.4 Amgen Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Amgen Recent Developments/Updates
  • 2.3 Tiefenbacher Pharmaceuticals
    • 2.3.1 Tiefenbacher Pharmaceuticals Details
    • 2.3.2 Tiefenbacher Pharmaceuticals Major Business
    • 2.3.3 Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Product and Services
    • 2.3.4 Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Tiefenbacher Pharmaceuticals Recent Developments/Updates
  • 2.4 UCB
    • 2.4.1 UCB Details
    • 2.4.2 UCB Major Business
    • 2.4.3 UCB Biologic Medications for Psoriasis Product and Services
    • 2.4.4 UCB Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 UCB Recent Developments/Updates
  • 2.5 Janssen Biotech
    • 2.5.1 Janssen Biotech Details
    • 2.5.2 Janssen Biotech Major Business
    • 2.5.3 Janssen Biotech Biologic Medications for Psoriasis Product and Services
    • 2.5.4 Janssen Biotech Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Janssen Biotech Recent Developments/Updates
  • 2.6 Eli Lilly
    • 2.6.1 Eli Lilly Details
    • 2.6.2 Eli Lilly Major Business
    • 2.6.3 Eli Lilly Biologic Medications for Psoriasis Product and Services
    • 2.6.4 Eli Lilly Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Eli Lilly Recent Developments/Updates
  • 2.7 AbbVie Biotechnology
    • 2.7.1 AbbVie Biotechnology Details
    • 2.7.2 AbbVie Biotechnology Major Business
    • 2.7.3 AbbVie Biotechnology Biologic Medications for Psoriasis Product and Services
    • 2.7.4 AbbVie Biotechnology Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 AbbVie Biotechnology Recent Developments/Updates
  • 2.8 Dalian Yawei Pharmaceutical
    • 2.8.1 Dalian Yawei Pharmaceutical Details
    • 2.8.2 Dalian Yawei Pharmaceutical Major Business
    • 2.8.3 Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Product and Services
    • 2.8.4 Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Dalian Yawei Pharmaceutical Recent Developments/Updates
  • 2.9 Novartis
    • 2.9.1 Novartis Details
    • 2.9.2 Novartis Major Business
    • 2.9.3 Novartis Biologic Medications for Psoriasis Product and Services
    • 2.9.4 Novartis Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Novartis Recent Developments/Updates
  • 2.10 Ortho Dermatologics
    • 2.10.1 Ortho Dermatologics Details
    • 2.10.2 Ortho Dermatologics Major Business
    • 2.10.3 Ortho Dermatologics Biologic Medications for Psoriasis Product and Services
    • 2.10.4 Ortho Dermatologics Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Ortho Dermatologics Recent Developments/Updates
  • 2.11 LEO Pharma
    • 2.11.1 LEO Pharma Details
    • 2.11.2 LEO Pharma Major Business
    • 2.11.3 LEO Pharma Biologic Medications for Psoriasis Product and Services
    • 2.11.4 LEO Pharma Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 LEO Pharma Recent Developments/Updates
  • 2.12 Kyowa Kirin
    • 2.12.1 Kyowa Kirin Details
    • 2.12.2 Kyowa Kirin Major Business
    • 2.12.3 Kyowa Kirin Biologic Medications for Psoriasis Product and Services
    • 2.12.4 Kyowa Kirin Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Kyowa Kirin Recent Developments/Updates
  • 2.13 Boehringer Ingelheim Pharmaceuticals
    • 2.13.1 Boehringer Ingelheim Pharmaceuticals Details
    • 2.13.2 Boehringer Ingelheim Pharmaceuticals Major Business
    • 2.13.3 Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Product and Services
    • 2.13.4 Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Boehringer Ingelheim Pharmaceuticals Recent Developments/Updates
  • 2.14 Pfizer
    • 2.14.1 Pfizer Details
    • 2.14.2 Pfizer Major Business
    • 2.14.3 Pfizer Biologic Medications for Psoriasis Product and Services
    • 2.14.4 Pfizer Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Pfizer Recent Developments/Updates
  • 2.15 Samsung Bioepis
    • 2.15.1 Samsung Bioepis Details
    • 2.15.2 Samsung Bioepis Major Business
    • 2.15.3 Samsung Bioepis Biologic Medications for Psoriasis Product and Services
    • 2.15.4 Samsung Bioepis Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Samsung Bioepis Recent Developments/Updates
  • 2.16 Qilu Pharmaceutical
    • 2.16.1 Qilu Pharmaceutical Details
    • 2.16.2 Qilu Pharmaceutical Major Business
    • 2.16.3 Qilu Pharmaceutical Biologic Medications for Psoriasis Product and Services
    • 2.16.4 Qilu Pharmaceutical Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Qilu Pharmaceutical Recent Developments/Updates
  • 2.17 Hanwha Chemical
    • 2.17.1 Hanwha Chemical Details
    • 2.17.2 Hanwha Chemical Major Business
    • 2.17.3 Hanwha Chemical Biologic Medications for Psoriasis Product and Services
    • 2.17.4 Hanwha Chemical Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Hanwha Chemical Recent Developments/Updates
  • 2.18 China Medical System
    • 2.18.1 China Medical System Details
    • 2.18.2 China Medical System Major Business
    • 2.18.3 China Medical System Biologic Medications for Psoriasis Product and Services
    • 2.18.4 China Medical System Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 China Medical System Recent Developments/Updates

3 Competitive Environment: Biologic Medications for Psoriasis by Manufacturer

  • 3.1 Global Biologic Medications for Psoriasis Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Biologic Medications for Psoriasis Revenue by Manufacturer (2021-2026)
  • 3.3 Global Biologic Medications for Psoriasis Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Biologic Medications for Psoriasis by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Biologic Medications for Psoriasis Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Biologic Medications for Psoriasis Manufacturer Market Share in 2025
  • 3.5 Biologic Medications for Psoriasis Market: Overall Company Footprint Analysis
    • 3.5.1 Biologic Medications for Psoriasis Market: Region Footprint
    • 3.5.2 Biologic Medications for Psoriasis Market: Company Product Type Footprint
    • 3.5.3 Biologic Medications for Psoriasis Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Biologic Medications for Psoriasis Market Size by Region
    • 4.1.1 Global Biologic Medications for Psoriasis Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Biologic Medications for Psoriasis Consumption Value by Region (2021-2032)
    • 4.1.3 Global Biologic Medications for Psoriasis Average Price by Region (2021-2032)
  • 4.2 North America Biologic Medications for Psoriasis Consumption Value (2021-2032)
  • 4.3 Europe Biologic Medications for Psoriasis Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Biologic Medications for Psoriasis Consumption Value (2021-2032)
  • 4.5 South America Biologic Medications for Psoriasis Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Biologic Medications for Psoriasis Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Biologic Medications for Psoriasis Sales Quantity by Type (2021-2032)
  • 5.2 Global Biologic Medications for Psoriasis Consumption Value by Type (2021-2032)
  • 5.3 Global Biologic Medications for Psoriasis Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Biologic Medications for Psoriasis Sales Quantity by Application (2021-2032)
  • 6.2 Global Biologic Medications for Psoriasis Consumption Value by Application (2021-2032)
  • 6.3 Global Biologic Medications for Psoriasis Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Biologic Medications for Psoriasis Sales Quantity by Type (2021-2032)
  • 7.2 North America Biologic Medications for Psoriasis Sales Quantity by Application (2021-2032)
  • 7.3 North America Biologic Medications for Psoriasis Market Size by Country
    • 7.3.1 North America Biologic Medications for Psoriasis Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Biologic Medications for Psoriasis Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Biologic Medications for Psoriasis Sales Quantity by Type (2021-2032)
  • 8.2 Europe Biologic Medications for Psoriasis Sales Quantity by Application (2021-2032)
  • 8.3 Europe Biologic Medications for Psoriasis Market Size by Country
    • 8.3.1 Europe Biologic Medications for Psoriasis Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Biologic Medications for Psoriasis Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Biologic Medications for Psoriasis Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Biologic Medications for Psoriasis Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Biologic Medications for Psoriasis Market Size by Region
    • 9.3.1 Asia-Pacific Biologic Medications for Psoriasis Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Biologic Medications for Psoriasis Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Biologic Medications for Psoriasis Sales Quantity by Type (2021-2032)
  • 10.2 South America Biologic Medications for Psoriasis Sales Quantity by Application (2021-2032)
  • 10.3 South America Biologic Medications for Psoriasis Market Size by Country
    • 10.3.1 South America Biologic Medications for Psoriasis Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Biologic Medications for Psoriasis Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Biologic Medications for Psoriasis Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Biologic Medications for Psoriasis Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Biologic Medications for Psoriasis Market Size by Country
    • 11.3.1 Middle East & Africa Biologic Medications for Psoriasis Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Biologic Medications for Psoriasis Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Biologic Medications for Psoriasis Market Drivers
  • 12.2 Biologic Medications for Psoriasis Market Restraints
  • 12.3 Biologic Medications for Psoriasis Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Biologic Medications for Psoriasis and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Biologic Medications for Psoriasis
  • 13.3 Biologic Medications for Psoriasis Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Biologic Medications for Psoriasis Typical Distributors
  • 14.3 Biologic Medications for Psoriasis Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Biologic Medications for Psoriasis market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Biologic medications for psoriasis are advanced therapeutic agents derived from living organisms that specifically target and modulate the immune system's activity involved in the disease.These medications are typically used for moderate to severe psoriasis and are administered through injections or infusions.
    This report is a detailed and comprehensive analysis for global Biologic Medications for Psoriasis market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Biologic Medications for Psoriasis market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Biologic Medications for Psoriasis market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Biologic Medications for Psoriasis market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Biologic Medications for Psoriasis market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Biologic Medications for Psoriasis
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Biologic Medications for Psoriasis market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol-Myers Squibb, Amgen, Tiefenbacher Pharmaceuticals, UCB, Janssen Biotech, Eli Lilly, AbbVie Biotechnology, Dalian Yawei Pharmaceutical, Novartis, Ortho Dermatologics, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Biologic Medications for Psoriasis market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    TNF-α Inhibitors
    Interleukin Inhibitors
    Tyrosine Kinase Inhibitors
    Phosphodiesterase Inhibitors
    Other
    Market segment by Application
    Hospital and Clinic
    Retail Pharmacies
    Other
    Major players covered
    Bristol-Myers Squibb
    Amgen
    Tiefenbacher Pharmaceuticals
    UCB
    Janssen Biotech
    Eli Lilly
    AbbVie Biotechnology
    Dalian Yawei Pharmaceutical
    Novartis
    Ortho Dermatologics
    LEO Pharma
    Kyowa Kirin
    Boehringer Ingelheim Pharmaceuticals
    Pfizer
    Samsung Bioepis
    Qilu Pharmaceutical
    Hanwha Chemical
    China Medical System
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Biologic Medications for Psoriasis product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Biologic Medications for Psoriasis, with price, sales quantity, revenue, and global market share of Biologic Medications for Psoriasis from 2021 to 2026.
    Chapter 3, the Biologic Medications for Psoriasis competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Biologic Medications for Psoriasis breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Biologic Medications for Psoriasis market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Biologic Medications for Psoriasis.
    Chapter 14 and 15, to describe Biologic Medications for Psoriasis sales channel, distributors, customers, research findings and conclusion.

    Buy now